Clyde, wouldn't you agree that time regarding the manufacturing rights is now on our side. The way I see this playing out is simply, BP will default when a formal request to supply is made and the Administrators not wanting to throw their money at a legal challenge will take whatever is offered hence the companies statement about the return of the rights not being materially detrimental to shareholders.
As for the market not knowing who we are or what we do, I'm sure whoever will ultimately buy the project will already know plenty about EMS.
With the Corporate restructure (Trade sale vehicle for Malarial assets) one can only assume things are getting closer.
I personally think Steve Carter has achieved more for the company in a shorter amount of time then his predecessors.
My opinion only, DYOR.
EMS Price at posting:
2.9¢ Sentiment: Hold Disclosure: Held
